Error: Could not add to watchlist. X

CFR Pharmaceuticals SA

+ Watchlist
CFR:CI
Acquired
CFR:CI was acquired by ABT:US
207.00
CLP
0.00
0.00%
As of 16:30:03 ET on 06/30/2015.
Open
207.00
Day Range
207.00 - 207.00
Volume
0
Previous Close
207.00
52Wk Range
140.00 - 215.00
Open
207.00
Day Range
207.00 - 207.00
Volume
0
Previous Close
207.00
52Wk Range
140.00 - 215.00
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-0.01
Market Cap (CLP)
-
Shares Outstanding (b)
8.416
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Specialty Pharma

Related Videos

There are currently no related videos for this ticker. Please check back later.
Profile
CFR Pharmaceuticals SA develops pharmaceuticals. The Company develops biopharmaceutical drugs for oncology, organ transplantation, dialysis, diabetes, autoimmune diseases, human immunodeficiency virus, epilepsy and respiratory diseases, injectables for anesthesia, cardiology and critical care, and oral contraconceptives, replacement hormone therapy and antiandrogens.
ADDRESS
Avenida Pedro de Valdivia 295
Providencia
Santiago
Chile
PHONE
56-2-350-52-14
  • Celestino Dos Anjos
    Chief Executive Officer
  • Claudio Gabriel Colombano
    Chief Operating Officer
  • Nicolas Weinstein Diaz
    CEO:Chile
  • Alejandro Diego Wellisch
    VP:Complex Therapeutics
  • Agustin Eguiguren Correa
    General Counsel
Show More